Research & Literature

Delay in the histopathologic diagnosis of mycosis fungoides.

Skov AG, Gniadecki R

Acta dermato-venereologica 2015; (95(4)):472-5 doi:10.2340/00015555-1971.

Defining early mycosis fungoides: validation of a diagnostic algorithm proposed by the International Society for Cutaneous Lymphomas.

Vandergriff T, Nezafati KA, Susa J, et al.

Journal of cutaneous pathology 2015; (42(5)):318-28 doi:10.1111/cup.12470.

Low-dose (10-Gy) total skin electron beam therapy for cutaneous T-cell lymphoma: an open clinical study and pooled data analysis.

Kamstrup MR, Gniadecki R, Iversen L, et al.

International journal of radiation oncology, biology, physics 2015; (92(1)):138-43.

Mycosis fungoides with epidermal mucinosis: a variant of mycosis fungoides with a spongiosis-like pattern.

Hu SW, Ratech H, Naeem R, et al.

Journal of cutaneous pathology 2015; (42(10)):730-8 doi:10.1111/cup.12513.

T-cell clonality assessment by next-generation sequencing improves detection sensitivity in mycosis fungoides.

Sufficool KE, Lockwood CM, Abel HJ, et al.

Journal of the American Academy of Dermatology 2015; (73(2)):228-36.e2.

Erythrodermic mycosis fungoides and Sézary syndrome treated with extracorporeal photopheresis as part of a multimodality regimen: A single-centre experience.

Atzmony L, Amitay-Laish I, Gurion R, et al.

Journal of the European Academy of Dermatology and Venereology : JEADV 2015; (29(12)):2382-9 doi:10.1111/jdv.13243.

Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype.

Amber KT, Bloom R, Nouri K

American journal of clinical dermatology 2016; (17(1)):71-7 doi:10.1007/s40257-015-0155-3.

Evaluation, Diagnosis, and Staging of Cutaneous Lymphoma.

Olsen EA

Dermatologic clinics 2015; (33(4)):643-54.

Extracorporeal Photopheresis in the Treatment of Mycosis Fungoides and Sézary Syndrome.

Zic JA

Dermatologic clinics 2015; (33(4)):765-76.

Granulomatous slack skin T-cell lymphoma: an important differential diagnosis with giant cell tumor of soft tissue.

Adriano AR, Lima TS, Battistella M, Bagot M

Anais brasileiros de dermatologia 2015; (90(6)):892-5.

Practical Aspects Regarding the Histopathological Diagnosis of Early Mycosis Fungoides.

Tebeică T, Andrei R, Zurac S, Stăniceanu F

Romanian journal of internal medicine = Revue roumaine de medecine interne 2016; (54(1)):3-10 doi:10.1515/rjim-2016-0001.

How I treat mycosis fungoides and Sézary syndrome.

Whittaker S, Hoppe R, Prince HM

Blood 2016; (127(25)):3142-53 doi:10.1182/blood-2015-12-611830.

[Unusual course of CD8+ epidermotropic cutaneous T-cell lymphoma].

Gardette E, Moguelet P, Barete S, et al.

Annales de dermatologie et de venereologie 2016; (143(12)):846-851 doi:10.1016/j.annder.2016.03.022.

Clinical Staging and Prognostic Factors in Folliculotropic Mycosis Fungoides.

van Santen S, Roach RE, van Doorn R, et al.

JAMA dermatology 2016; (152(9)):992-1000 doi:10.1001/jamadermatol.2016.1597.

Phase I/II study of the oral retinoid X receptor agonist bexarotene in Japanese patients with cutaneous T-cell lymphomas.

Hamada T, Sugaya M, Tokura Y, et al.

The Journal of dermatology 2017; (44(2)):135-142 doi:10.1111/1346-8138.13542.

CD8-positive Mycosis Fungoides Masquerading as Pyoderma Gangrenosum.

Saha M, Jain BB, Chattopadhyay S, Podder I

Indian journal of dermatology 2016; (61(5)):580 doi:10.4103/0019-5154.190126.

Recommendations for treatment in folliculotropic mycosis fungoides: report of the Dutch Cutaneous Lymphoma Group.

van Santen S, van Doorn R, Neelis KJ, et al.

The British journal of dermatology 2017; (177(1)):223-228 doi:10.1111/bjd.15355.

Omega-3 fatty acids as adjunctive treatment for bexarotene-induced hypertriglyceridaemia in patients with cutaneous T-cell lymphoma.

Cabello I, Servitje O, Corbella X, et al.

Clinical and experimental dermatology 2017; (42(3)):276-281 doi:10.1111/ced.13044.

Clinical characteristics, risk factors and long-term outcome of 114 patients with folliculotropic mycosis fungoides.

Wieser I, Wang C, Alberti-Violetti S, et al.

Archives of dermatological research 2017; (309(6)):453-459 doi:10.1007/s00403-017-1744-1.

Extracorporeal photochemotherapy in mycosis fungoides.

Atilla E, Atilla PA, Bozdag SC, et al.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine 2017; (24(4)):454-457 doi:10.1016/j.tracli.2017.05.001.

Syringotropic Mycosis Fungoides: A Rare Form of Cutaneous T-cell Lymphoma Enabling a Histopathologic "Sigh of Relief".

Lehmer LM, Amber KT, de Feraudy SM

The American Journal of dermatopathology 2017; (39(12)):920-923 doi:10.1097/DAD.0000000000000926.

Early clinical manifestations of Sézary syndrome: A multicenter retrospective cohort study.

Mangold AR, Thompson AK, Davis MD, et al.

Journal of the American Academy of Dermatology 2017; (77(4)):719-727 doi:10.1016/j.jaad.2017.05.036.

Brentuximab vedotin therapy for CD30-positive cutaneous T-cell lymphoma: a targeted approach to management.

Scarisbrick JJ

Future oncology (London, England) 2017; (13(27)):2405-2411 doi:10.2217/fon-2017-0263.

Cutaneous T-cell lymphoma: 2017 update on diagnosis, risk-stratification, and management.

Wilcox RA

American journal of hematology 2017; (92(10)):1085-1102 doi:10.1002/ajh.24876.

Granulomatous slack skin: a rare subtype of mycosis fungoides.

Motta LMD, Soares CT, Nakandakari S, et al.

Anais brasileiros de dermatologia 2017; (92(5)):694-697 doi:10.1590/abd1806-4841.20175099.

Folliculotropism Does Not Affect Overall Survival in Mycosis Fungoides: Results from a Single-Center Cohort and Meta-Analysis.

Giberson M, Mourad A, Gniadecki R

Dermatology (Basel, Switzerland) 2017; (233(4)):320-325 doi:10.1159/000484203.

Relationship Between Pityriasis Lichenoides and Mycosis Fungoides: A Clinicopathological, Immunohistochemical, and Molecular Study.

Zaaroura H, Sahar D, Bick T, Bergman R

The American Journal of dermatopathology 2018; (40(6)):409-415 doi:10.1097/DAD.0000000000001057.

Unusual variants of mycosis fungoides.

Virmani P, Myskowski PL, Pulitzer M

Diagnostic histopathology (Oxford, England) 2016; (22(4)):142-151 doi:10.1016/j.mpdhp.2016.04.004.

Nodal Involvement by CD30+ Cutaneous Lymphoproliferative Disorders and Its Challenging Differentiation From Classical Hodgkin Lymphoma.

Lezama LS, Gratzinger D

Archives of pathology & laboratory medicine 2018; (142(1)):139-142 doi:10.5858/arpa.2016-0352-RS.

Blood classification and blood response criteria in mycosis fungoides and Sézary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force.

Scarisbrick JJ, Hodak E, Bagot M, et al.

European journal of cancer (Oxford, England : 1990) 2018; (93()):47-56 doi:10.1016/j.ejca.2018.01.076.

Large-Cell Transformed Mycosis Fungoides Coexisting with Mycosis Fungoides Bullosa: A Case Report and Review of the Literature.

Porntharukcharoen S, Rutnin S, Rajatanavin N

Case reports in dermatology 2017; (9(3)):243-248 doi:10.1159/000484472.

Phototherapy as a first-line treatment for early-stage mycosis fungoides: The results of a large retrospective analysis.

Nikolaou V, Sachlas A, Papadavid E, et al.

Photodermatology, photoimmunology & photomedicine 2018; (34(5)):307-313 doi:10.1111/phpp.12383.

High-throughput sequencing of the T cell receptor β gene identifies aggressive early-stage mycosis fungoides.

de Masson A, O'Malley JT, Elco CP, et al.

Science translational medicine 2018; (10(440)) doi:10.1126/scitranslmed.aar5894.

Inflammatory cytokines and peripheral mediators in the pathophysiology of pruritus in cutaneous T-cell lymphoma.

Lewis DJ, Huang S, Duvic M

Journal of the European Academy of Dermatology and Venereology : JEADV 2018; (32(10)):1652-1656 doi:10.1111/jdv.15075.

New Therapies and Immunological Findings in Cutaneous T-Cell Lymphoma.

Fujii K

Frontiers in oncology 2018; (8()):198 doi:10.3389/fonc.2018.00198.

Pruritus in Cutaneous T-Cell Lymphoma and Its Management.

Serrano L, Martinez-Escala ME, Zhou XA, Guitart J

Dermatologic clinics 2018; (36(3)):245-258 doi:10.1016/j.det.2018.02.011.

[Acrally emphasized papules-a case report].

Marovt M, Luzar B, Marko PB

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 2019; (70(1)):44-46 doi:10.1007/s00105-018-4227-1.

[Importance of phototherapy in the treatment of chronic pruritus].

Legat FJ

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 2018; (69(8)):631-640 doi:10.1007/s00105-018-4229-z.

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.

Kim YH, Bagot M, Pinter-Brown L, et al.

The Lancet. Oncology 2018; (19(9)):1192-1204 doi:10.1016/S1470-2045(18)30379-6.

Reflectance confocal microscopy as a first-line diagnostic technique for mycosis fungoides.

Yeager DG, Noor O, Rao BK

Cutis 2018; (102(1)):56-58.

Interferon alfa-2a maintenance after salvage autologous stem cell transplantation in atypical mycosis fungoides with central nervous system involvement.

Doerschner M, Pekar-Lukacs A, Messerli-Odermatt O, et al.

The British journal of dermatology 2019; (181(6)):1296-1302 doi:10.1111/bjd.17535.

Comparison of Narrowband UV-B With Psoralen-UV-A Phototherapy for Patients With Early-Stage Mycosis Fungoides: A Systematic Review and Meta-analysis.

Phan K, Ramachandran V, Fassihi H, Sebaratnam DF

JAMA dermatology 2019; (155(3)):335-341 doi:10.1001/jamadermatol.2018.5204.

Evaluation of Low-Dose, Low-Frequency Oral Psoralen-UV-A Treatment With or Without Maintenance on Early-Stage Mycosis Fungoides: A Randomized Clinical Trial.

Vieyra-Garcia P, Fink-Puches R, Porkert S, et al.

JAMA dermatology 2019; (155(5)):538-547 doi:10.1001/jamadermatol.2018.5905.

Bexarotene-induced hypothyroidism: Characteristics and therapeutic strategies.

Makita N, Manaka K, Sato J, et al.

Clinical endocrinology 2019; (91(1)):195-200 doi:10.1111/cen.13975.

Syringotropic Mycosis Fungoides: A Variant of Folliculotropic Mycosis Fungoides or a Distinct Entity?

Echols KF, Bressler L, Armeson K, Maize JC

The American Journal of dermatopathology 2019; (41(11)):807-809 doi:10.1097/DAD.0000000000001403.

Mycosis fungoides with spongiosis: A potential diagnostic pitfall.

Shamim H, Johnson EF, Gibson LE, Comfere N

Journal of cutaneous pathology 2019; (46(9)):645-652 doi:10.1111/cup.13477.

Mycosis fungoides and Sézary syndrome: 2019 update on diagnosis, risk-stratification, and management.

Hristov AC, Tejasvi T, Wilcox RA

American journal of hematology 2019; (94(9)):1027-1041 doi:10.1002/ajh.25577.

FDA Approval Summary: Mogamulizumab-kpkc for Mycosis Fungoides and Sézary Syndrome.

Kasamon YL, Chen H, de Claro RA, et al.

Clinical cancer research : an official journal of the American Association for Cancer Research 2019; (25(24)):7275-7280 doi:10.1158/1078-0432.CCR-19-2030.

Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysis.

Goyal A, O'Leary D, Goyal K, et al.

Journal of the American Academy of Dermatology 2020; (83(2)):404-411 doi:10.1016/j.jaad.2019.07.075.

Plaque stage folliculotropic mycosis fungoides: histopathologic features and prognostic factors in a series of 40 patients.

van Santen S, Jansen PM, Quint KD, et al.

Journal of cutaneous pathology 2020; (47(3)):241-250 doi:10.1111/cup.13615.

Efficacy of narrow-band ultraviolet-B therapy in patch-stage mycosis fungoides: A clinical study and review of the literature.

Atci T, Baykal C

Photodermatology, photoimmunology & photomedicine 2020; (36(4)):271-277 doi:10.1111/phpp.12547.

NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020.

Mehta-Shah N, Horwitz SM, Ansell S, et al.

Journal of the National Comprehensive Cancer Network : JNCCN 2020; (18(5)):522-536.

Folliculotropic mycosis fungoides: Clinical characteristics, treatments, and long-term outcomes of 53 patients in a tertiary hospital.

Kalay Yildizhan I, Sanli H, Akay BN, et al.

Dermatologic therapy 2020; (33(4)):e13585 doi:10.1111/dth.13585.

Response to topical corticosteroid monotherapy in mycosis fungoides.

Kartan S, Shalabi D, O'Donnell M, et al.

Journal of the American Academy of Dermatology 2021; (84(3)):615-623 doi:10.1016/j.jaad.2020.05.043.

Extracorporeal Photopheresis: A Case of Immunotherapy Ahead of Its Time.

Vieyra-Garcia PA, Wolf P

Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie 2020; (47(3)):226-235 doi:10.1159/000508479.

Pathogenesis and Therapy of Primary Cutaneous T-Cell Lymphoma: Collegium Internationale Allergologicum (CIA) Update 2020.

Bobrowicz M, Fassnacht C, Ignatova D, et al.

International archives of allergy and immunology 2020; (181(10)):733-745 doi:10.1159/000509281.

Cutaneous T-cell lymphoma is associated with increased risk of lymphoma, melanoma, lung cancer, and bladder cancer.

Goyal A, O'Leary D, Goyal K, et al.

Journal of the American Academy of Dermatology 2021; (85(6)):1418-1428 doi:10.1016/j.jaad.2020.06.1033.

Cicatricial Alopecia Related to Folliculotropic Mycosis Fungoides.

Kreutzer KM, Effendy I

Dermatology and therapy 2020; (10(5)):1175-1180 doi:10.1007/s13555-020-00429-0.

The importance of assessing blood tumour burden in cutaneous T-cell lymphoma.

Vermeer MH, Nicolay JP, Scarisbrick JJ, Zinzani PL

The British journal of dermatology 2021; (185(1)):19-25 doi:10.1111/bjd.19669.

Evaluating the Treatment Patterns of Chlormethine/Mechlorethamine Gel in Patients With Stage I-IIA Mycosis Fungoides: By-time Reanalysis of a Randomized Controlled Phase 2 Study.

Geskin LJ, Kim EJ, Angello JT, Kim YH

Clinical lymphoma, myeloma & leukemia 2021; (21(2)):119-124.e4 doi:10.1016/j.clml.2020.11.022.

Mogamulizumab-kpkc: A Novel Therapy for the Treatment of Cutaneous T-Cell Lymphoma.

Watson S, Marx JB

Journal of the advanced practitioner in oncology 2019; (10(8)):883-888 doi:10.6004/jadpro.2019.10.8.10.

Acneiform Presentations of Folliculotropic Mycosis Fungoides.

Shamim H, Riemer C, Weenig R, et al.

The American Journal of dermatopathology 2021; (43(2)):85-92 doi:10.1097/DAD.0000000000001698.

Mycosis fungoides of the vulva.

Tjalma WAA, Janssens M, Dam K, et al.

Northern clinics of Istanbul 2021; (8(1)):101-105 doi:10.14744/nci.2020.12129.

Erythrodermic CD4/CD8 Double-Negative Mycosis Fungoides: A Case Report.

Alnasser MA, AlKhawajah NM, AlQadri NG, et al.

Case reports in oncology 2021; (14(1)):256-261 doi:10.1159/000512822.

Response to brentuximab vedotin versus physician's choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysis.

Kim YH, Prince HM, Whittaker S, et al.

European journal of cancer (Oxford, England : 1990) 2021; (148()):411-421 doi:10.1016/j.ejca.2021.01.054.

Phototherapy.

Barros NM, Sbroglio LL, Buffara MO, et al.

Anais brasileiros de dermatologia 2021; (96(4)):397-407 doi:10.1016/j.abd.2021.03.001.

Phototherapy as a treatment of early-stage mycosis fungoides and predictive factors for disease recurrence: A 17-year retrospective study.

Rattanakaemakorn P, Ploydaeng M, Udompanich S, et al.

Indian journal of dermatology, venereology and leprology 2021; (87(5)):645-650.

Chlormethine Gel in Combination with Other Therapies in the Treatment of Patients with Mycosis Fungoides Cutaneous T Cell Lymphoma: Three Case Reports.

Lampadaki K, Koumourtzis M, Karagianni F, et al.

Advances in therapy 2021; (38(6)):3455-3464 doi:10.1007/s12325-021-01721-x.

Screening for second malignancies in mycosis fungoides: non-Hodgkin lymphoma, Hodgkin lymphoma, lung cancer, bladder cancer and melanoma.

Goyal A, O'Leary D, Goyal K, et al.

Journal of the European Academy of Dermatology and Venereology : JEADV 2021; (35(9)):1821-1829 doi:10.1111/jdv.17384.

Real-life experience with chlormethine gel for early-stage mycosis fungoides with emphasis on types and management of cutaneous side-effects.

Prag Naveh H, Amitay-Laish I, Zidan O, et al.

The Journal of dermatological treatment 2022; (33(4)):2364-2370 doi:10.1080/09546634.2021.1967266.

Characteristics and outcomes of 727 patients with mycosis fungoides and Sézary syndrome from a Brazilian cohort.

Miyashiro D, Sanches JA

International journal of dermatology 2022; (61(4)):442-454 doi:10.1111/ijd.15865.

Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician's choice in cutaneous T-cell lymphoma: final data.

Horwitz SM, Scarisbrick JJ, Dummer R, et al.

Blood advances 2021; (5(23)):5098-5106 doi:10.1182/bloodadvances.2021004710.

Diagnosis of Early Mycosis Fungoides.

Miyagaki T

Diagnostics (Basel, Switzerland) 2021; (11(9)) doi:10.3390/diagnostics11091721.

PEG10 amplification at 7q21.3 potentiates large-cell transformation in cutaneous T-cell lymphoma.

Liu F, Gao Y, Xu B, et al.

Blood 2022; (139(4)):554-571 doi:10.1182/blood.2021012091.

Single-cell RNA sequencing reveals markers of disease progression in primary cutaneous T-cell lymphoma.

Rindler K, Jonak C, Alkon N, et al.

Molecular cancer 2021; (20(1)):124 doi:10.1186/s12943-021-01419-2.

Nivolumab in two cases of refractory mycosis fungoides erythroderma.

Chmielowska E

Central-European journal of immunology 2021; (46(4)):535-538 doi:10.5114/ceji.2021.111453.

Flow cytometry for the assessment of blood tumour burden in cutaneous T-cell lymphoma: towards a standardized approach.

Vermeer MH, Moins-Teisserenc H, Bagot M, et al.

The British journal of dermatology 2022; (187(1)):21-28 doi:10.1111/bjd.21053.

Woringer-Kolopp disease (localized pagetoid reticulosis): a systematic review.

Osto M, Afify O, Musa A, et al.

International journal of dermatology 2023; (62(3)):312-321 doi:10.1111/ijd.16224.

New developments in skin-directed treatments of cutaneous T-cell lymphoma.

Amitay-Laish I, Hodak E

Presse medicale (Paris, France : 1983) 2022; (51(1)):104125 doi:10.1016/j.lpm.2022.104125.

Mitigation strategies among cutaneous T-cell lymphoma patients with positive Staphylococcus aureus skin and soft tissue cultures have unclear impacts on the risk of subsequent bacteremia.

Allen PB, Goyal S, Switchenko J, et al.

Leukemia & lymphoma 2023; (64(3)):597-604 doi:10.1080/10428194.2022.2081324.

[Radiotherapy for cutaneous lymphomas].

Rolf D, Eich HT

Dermatologie (Heidelberg, Germany) 2022; (73(10)):772-781 doi:10.1007/s00105-022-05046-w.

Malignant T cells induce skin barrier defects through cytokine-mediated JAK/STAT signaling in cutaneous T-cell lymphoma.

Gluud M, Pallesen EMH, Buus TB, et al.

Blood 2023; (141(2)):180-193 doi:10.1182/blood.2022016690.

Cutaneous T-cell Lymphoma Predisposing to Recurrent Infective Endocarditis by Methicillin-resistant Staphylococcus Aureus (MRSA) in a Patient with Intracardiac Defibrillator (ICD).

Shah MA, Soofi MA, Alsmadi F, et al.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 2022; (32(8)):S95-S97 doi:10.29271/jcpsp.2022.Supp2.S95.

Cutaneous T-cell lymphomas: 2023 update on diagnosis, risk-stratification, and management.

Hristov AC, Tejasvi T, Wilcox RA

American journal of hematology 2023; (98(1)):193-209 doi:10.1002/ajh.26760.

Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion.

Hodak E, Geskin L, Guenova E, et al.

American journal of clinical dermatology 2023; (24(1)):5-14 doi:10.1007/s40257-022-00732-w.

Staging lymph nodes and blood at diagnosis in mycosis fungoides identifies patients at increased risk of progression to advanced stage: A retrospective cohort study.

Allen PB, McCook-Veal AA, Switchenko JM, et al.

Cancer 2023; (129(4)):541-550 doi:10.1002/cncr.34579.

Risk of skin cancers in mycosis fungoides patients receiving PUVA therapy: A real-life experience from a single tertiary center.

Doğan PE, Akay BN, Vural S, et al.

Photodermatology, photoimmunology & photomedicine 2023; (39(5)):428-434 doi:10.1111/phpp.12872.

Single-Fraction Radiation Therapy for Localized Cutaneous T-Cell Lymphoma.

Wang P, Gilbert M, Lim HW, et al.

Practical radiation oncology 2023; (13(4)):346-350 doi:10.1016/j.prro.2023.03.015.

Mycosis fungoides and Sézary syndrome: clinical presentation, diagnosis, staging, and therapeutic management.

Miyashiro D, Sanches JA

Frontiers in oncology 2023; (13()):1141108 doi:10.3389/fonc.2023.1141108.

Immediate Response to Brentuximab Vedotin in a Patient with Localized MF-LCT.

Giza A, Miklusiak K, Hałubiec P, et al.

Case reports in dermatology 2023; (15(1)):110-116 doi:10.1159/000529576.

Oral Mycosis Fungoides: Report of 2 Cases and Review of the Literature.

Alexander-Savino C, Boye-Doe A, Bowers E, Beaven A

Case reports in dermatology 2023; (15(1)):1 doi:10.1159/000530935.

Anaplastic Large Cell Transformation of Mycosis Fungoides: Case Report and Review of the Literature.

Flerova E, Alpdogan O, Bhatti S, et al.

The American Journal of dermatopathology 2023; (45(9)):e74-e82 doi:10.1097/DAD.0000000000002527.

EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2023.

Latzka J, Assaf C, Bagot M, et al.

European journal of cancer (Oxford, England : 1990) 2023; (195()):113343 doi:10.1016/j.ejca.2023.113343.

What's New in Cutaneous T-Cell Lymphoma-Associated Pruritus.

Biazus Soares G, Guitart J, Yosipovitch G

American journal of clinical dermatology 2024; (25(1)):67-77 doi:10.1007/s40257-023-00823-2.

Mycosis Fungoides and Granulomatous Slack Skin: A Single Entity With Distinct Clinical Phenotypes.

Bakr F, Ziaj S, Cardoso J, et al.

The American Journal of dermatopathology 2024; (46(1)):14-20 doi:10.1097/DAD.0000000000002590.

Decoding Early Mycosis Fungoides: Histopathologic and Immunohistochemical Clues.

Kaya Terzi N

Cureus 2024; (16(4)):e57545 doi:10.7759/cureus.57545.

Characterization of cells and mediators associated with pruritus in primary cutaneous T-cell lymphomas.

Hu M, Scheffel J, Frischbutter S, et al.

Clinical and experimental medicine 2024; (24(1)):171 doi:10.1007/s10238-024-01407-y.

When mycosis fungoides seems not to be within the spectrum of clinical and histopathological differential diagnoses.

Di Prete M, Michelerio A, Lora V, et al.

Dermatology reports 2024; (16(Suppl 2)):10008 doi:10.4081/dr.2024.10008.

Mycosis Fungoides, Sézary Syndrome, and Cutaneous B-Cell Lymphomas: 2025 Update on Diagnosis, Risk-Stratification, and Management.

Hristov AC, Tejasvi T, Wilcox RA

American journal of hematology 2025; (100(9)):1603-1628 doi:10.1002/ajh.27735.

Large-cell transformation of mycosis fungoides: Patterns of care and patient outcomes.

Johnstone P, Higgins M, Prince HM, et al.

British journal of haematology 2025; (207(3)):824-833 doi:10.1111/bjh.20225.

Pruritus Is an Indicator for Quality of Life in Cutaneous T-Cell Lymphoma.

Roggo A, Wüest Y, Dummer R, Ramelyte E

The Journal of dermatology 2025; (52(9)):1404-1410 doi:10.1111/1346-8138.17847.

Prognostic Value of Immunohistochemical T-Cell Marker Loss in Early-Stage Mycosis Fungoides: A Single-Center Cohort Study.

Jerkovic Gulin S, Ilic I, Gulin D, et al.

Dermatopathology (Basel, Switzerland) 2025; (12(3)) doi:10.3390/dermatopathology12030029.

Allogeneic hematopoietic cell transplant in cutaneous T-cell lymphomas: recommendations from the EBMT PH&G Committee.

Damaj G, de Masson A, Dreger P, et al.

Bone marrow transplantation 2025; (60(12)):1565-1573 doi:10.1038/s41409-025-02696-x.

A historical review of mycosis fungoides: from Alibert to mogamulizumab.

Johnson NA, Fariyike O, Mistry K, et al.

Skin health and disease 2026; (6(1)):30-34 doi:10.1093/skinhd/vzaf099.

Efficacy and Safety of Mogamulizumab for Cutaneous T-Cell Lymphomas: A Systematic Review and Meta-Analysis.

Lawal A, Rangel AR, Raja A, et al.

Clinical lymphoma, myeloma & leukemia 2026; (26(7)):436-446.e8 doi:10.1016/j.clml.2026.04.014.

Current state of medical care for patients with mycosis fungoides and Sézary syndrome at a German university hospital - a cross-sectional study.

Hansen-Abeck I, Kölln L, Abeck F, et al.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2026; doi:10.1111/ddg.70194x.

Inflammatory and Infectious Cutaneous Entities Resembling Cutaneous T-Cell Lymphoma (CTCL): An Integrated Clinicopathological Review.

Nasser Eldin J, El Tayar E, Abbas O, Bhawan J

Dermatopathology (Basel, Switzerland) 2026; (13(2)) doi:10.3390/dermatopathology13020023.

Comparison of narrowband ultraviolet B with psoralen plus ultraviolet A phototherapy for patients with early-stage mycosis fungoides: a systematic review and meta-analysis.

Bano S, Sidra FNU, Venjhraj FNU, et al.

Skin health and disease 2026; (6(4)):406-414 doi:10.1093/skinhd/vzag055.

Adverse events associated with systemic cutaneous T-cell lymphoma therapies: a narrative review.

Nayudu K, Thompson BB, Larocca C

Frontiers in medicine 2026; (13()):1912209 doi:10.3389/fmed.2026.1912209.